15-day Paxlovid regimen safe but adds no clear long-COVID benefit, trial finds

ECOG-ACRIN completes first trial of Black patients with early-stage breast cancer - EurekAlert

Scientists Race To Perfect New Oral COVID-19 Treatment Poised To Replace Paxlovid

World-first trial shows benefits of finding, treating undiagnosed asthma and COPD - EurekAlert